Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2019 2020

Details for Mechanism ID: 17562
Country/Region: Dominican Republic
Year: 2016
Main Partner: Centro de Orientacion e Investigacion Integral
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $729,298 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $72,933
Testing: HIV Testing and Counseling (HVCT) $19,630
Treatment: Adult Treatment (HTXS) $636,735
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV Age/Sex: 20-24 Female 2017 10
GEND_GBV Age/Sex: 25-49 Female 2017 10
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 20
GEND_GBV Number of people receiving post-GBV care 2017 20
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 3,992
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 3,993
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 7,985
HTS_TST Service Delivery Point (Facility): Other PITC 2017 7,985
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 7,985
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 7,985
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 214
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 214
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 370
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 370
TB_SCREENDX Screen Result: Screened Positive for TB 2017 410
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 824
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 825
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 4,091
TX_CURR Aggregated Age/Sex: 15+ Female 2017 2,272
TX_CURR Aggregated Age/Sex: 15+ Male 2017 2,273
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 4,545
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 4,545
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 4,545
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 917
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 916
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 1,833
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 1,833
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 3,636
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 2,909
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 1,454
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 1,455
TX_PVLS Numerator: Indication: Routine 2017 2,593
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 1,817
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 1,819
TX_PVLS_den Denominator: Indication: Routine 2017 2,849
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,152
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,153
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 2,305
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 2,711
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,355
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,356